Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2023 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

MEDICAL RESEARCH
Published

FDA approves Gilead's hepatitis C drug for expanded use

By | Reuters
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. Picture taken August 14, 2012. REUTERS/Jason Reed

A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. Picture taken August 14, 2012. REUTERS/Jason Reed (Copyright Reuters 2015)

Drugmaker Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration approved the expanded use of its blockbuster hepatitis C drug, Harvoni.

The drug can now be used to treat patients with subtypes of chronic hepatitis C virus (HCV) and in patients who are co-infected with Human Immunodeficiency Virus (HIV), Gilead said in a statement

(Reporting by Rosmi Shaji in Bengaluru; Editing by Anil D'Silva)